Celularity IncNASDAQ:CELU
- LAST PRICE3.3800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.3500/ 1
- Ask / Lots5.4000/ 2
- Open / Previous Close0.0000 / 3.3800
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CELU |
|---|---|---|
| 09:32 ET | 298 | 3.23 |
| 09:34 ET | 1612 | 3.2101 |
| 09:48 ET | 400 | 3.35 |
| 10:50 ET | 1000 | 3.3126 |
| 11:06 ET | 200 | 3.335 |
| 11:24 ET | 2900 | 3.27 |
| 11:45 ET | 1200 | 3.25 |
| 12:05 ET | 100 | 3.28 |
| 12:30 ET | 2520 | 3.285 |
| 12:39 ET | 100 | 3.3 |
| 01:03 ET | 138 | 3.29 |
| 01:17 ET | 100 | 3.29 |
| 01:50 ET | 200 | 3.29 |
| 01:53 ET | 100 | 3.29 |
| 02:02 ET | 100 | 3.25 |
| 02:15 ET | 100 | 3.29 |
| 02:27 ET | 100 | 3.33 |
| 02:51 ET | 300 | 3.3 |
| 02:58 ET | 100 | 3.35 |
| 03:07 ET | 100 | 3.305 |
| 03:23 ET | 100 | 3.35 |
| 03:27 ET | 600 | 3.4 |
| 03:30 ET | 147 | 3.38 |
| 03:32 ET | 300 | 3.35 |
| 03:34 ET | 400 | 3.35 |
| 03:36 ET | 464 | 3.35 |
| 03:38 ET | 500 | 3.35 |
| 03:39 ET | 700 | 3.38 |
| 03:41 ET | 726 | 3.355 |
| 03:43 ET | 1012 | 3.35 |
| 03:45 ET | 800 | 3.35 |
| 03:48 ET | 1000 | 3.35 |
| 03:50 ET | 800 | 3.35 |
| 03:52 ET | 973 | 3.355 |
| 03:54 ET | 500 | 3.35 |
| 03:56 ET | 5751 | 3.44 |
| 03:57 ET | 1703 | 3.39 |
| 03:59 ET | 907 | 3.38 |
Apr 22, 2024
Celularity Inc. to Host Investor and Analyst Research & Development Day, from 8:00AM ET on Monday Apr 22, 2024 by Dow Jones
8:00AM ET on Monday Apr 22, 2024 by Dow Jones
Apr 19, 2024
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing, from 5:30PM ET on Friday Apr 19, 2024 by Dow Jones
5:30PM ET on Friday Apr 19, 2024 by Dow Jones
Apr 18, 2024
Apr 15, 2024
Apr 8, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Celularity Inc | 73.6M | -0.3x | --- |
Turnstone Biologics Corp | 70.9M | -1.1x | --- |
Gritstone bio Inc | 86.1M | -0.5x | --- |
Aligos Therapeutics Inc | 62.7M | -0.5x | --- |
Prenetics Global Ltd | 58.5M | -1.0x | --- |
ImmuCell Corp | 39.1M | -6.8x | --- |
Company Information
Celularity Inc. is a clinical-stage biotechnology company. The Company is engaged in developing off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through three business segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapy product candidates include T cells engineered with a chimeric antigen receptor (CAR), natural killer, cells, mesenchymal-like adherent stromal cells (MLASCs), and exosomes. These therapeutic candidates target indications across cancer, infectious and degenerative diseases. Its cell therapeutic programs include CYCART-19, CYCART-201, CYNK-001, CYNK-301, CYNK-302, APPL-001, and pEXO-001. CYCART-19 is a placental-derived CAR-T cell therapy, in development for the treatment of B-cell malignancies, initially targeting the cluster of differentiation 19. pExo-001 is developed for the treatment of osteoarthritis. APPL-001 is developed for the treatment of Crohn’s disease.
Contact Information
- Headquarters
- 170 Park AveFLORHAM PARK, NJ, United States 07932
- Phone
- 908-768-2170
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer
- Robert Hariri
- Chief Financial Officer
- David Beers
- President - Degenerative Disease
- Stephen Brigido
- Senior Executive Vice President, Chief Administrative Officer, General Manager
- John Haines
- Director
- Shiu Fei Ling
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $73.6M |
|---|---|
Revenue (TTM) | $14.8M |
Shares Outstanding | 21.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $-10.51 |
Book Value | $13.36 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 5.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,272.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
